99 reports

Global Laboratory Reagents Industry LABORATORY REAGENTS MCP-## MARKET ANALYSIS, TRENDS, AND FORECASTS, MAY ## CONTENTS ##.

  • Protein Therapy
  • APAC
  • Japan
  • United States
  • World

Take bioengineering medicine as main one and natural medicine and medicine preparation as supplement.

  • Protein Therapy
  • China
  • Demand
  • Market Size
  • Supply

THE PIPELINE FOCUSES ON NOVEL PHARMACOLOGIC DRUGS & REGENERATIVE MEDICINES COVERING SMALL MOLECULES, ANTIBODIES, STEM CELL THERAPIES, RECOMBINANT PROTEINS AND RNA-BASED THERAPEUTICS, BUT EXCLUDES SYMPTOM RELIEF DRUGS, GENERIC COMBINATIONS AND SUPPLEMENTAL DRUGS.

  • Protein Therapy
  • Allergan plc
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cerenis

II-## Systemic Enzymes for Nutritional Support throughout the Body II-## Regenerative Medicine: A Niche Market Beckons II-## Increasing Consumption in Health Supplements Augurs Well for the Market..............

  • Protein Therapy
  • APAC
  • Japan
  • World
  • Demand
  • HEMOADSORPTION DEVICE - SEPSIS - PRODUCT DESCRIPTION

The institute also educates scientists and engineers developing technologies related to regenerative medicine and trains clinicians in the use of regenerative therapies.

  • Blood Supply
  • Clinical Trial
  • Hospital
  • Protein Therapy
  • CytoSorbents Corporation
  • ATROSIMAB - DRUG PROFILE

It has partnership with other oncology medicine center.

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • Protein Therapy
  • Therapy
  • Jul 24, 2017: Sernova-HemAcure Consortium Announce Significant Progress in Development of 'First in World' Regenerative Medicine Therapy for Treatment of Hemophilia A Patients

This is a strong validation of the Consortium' s dedication and teamwork and the importance of this regenerative medicine approach, " said Dr.

  • Blood Disease
  • Cell Therapy
  • Clinical Trial
  • Protein Therapy
  • Therapy

THE PROGENITOR CELLS TO TREAT FULMINANT HEPATITIS BY PROCUREMENT OF A POOL OF DIVIDING AND FUNCTIONING CELLS TO PROMOTE LIVER REGENERATION.

  • Blood Disease
  • Protein Therapy
  • Therapy
  • United States
  • Product Initiative

It deals in the manufacture of medical devices, pharmaceuticals and biotechnology products; BioScience: The Bioscience business processes recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-## ant

  • Protein Therapy
  • World
  • Baxter International Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • PIPELINE BY CYTOVIA INC, H2 2018
  • PIPELINE BY CANTEX PHARMACEUTICALS INC, H2 2018

The company provides drug portfolio within the field of pharmaceutical regenerative medicine.

  • Immunotherapy
  • Medical Biotechnology
  • Pharmaceutical
  • Protein Therapy
  • Therapy

By 2020, the Japanese government plans to expand its market of pharmaceuticals, medical devices, and regenerative medicines by ##%.

  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • Protein Therapy
  • Chugai Pharmaceutical Co., Ltd.
  • Target

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiology
  • Clinical Trial
  • Hospital
  • Medical Biotechnology
  • Protein Therapy
  • Target

The prominent features of this report are - ##.

  • Autoimmune Disease
  • Clinical Trial
  • Medical Biotechnology
  • Monoclonal Antibody
  • Protein Therapy

The prominent features of this report are - ##.

  • Clinical Trial
  • Dementia
  • Immunotherapy
  • Neurology
  • Protein Therapy

## ## ## ## ## ## ## ## MallInckrodt Plc ## ## ## ## ## ## ## ## Syneos Health Inc ## ## ## ## ## ## ## ## Sun Pharmaceutical Industries Ltd ## ## ## ## ## ## ## ## Pfizer Inc Noveome Biotherapeutics Inc Fresenius SE & Co KGaA Fibrocell Science Inc Bayer AG ##

  • Clinical Trial
  • Protein Therapy
  • Therapy
  • World
  • MediWound Ltd.

A Non-inferiority Trial Periodontal Regeneration with Platelet-rich Fibrin (PRF) and Autogenous Bone Graft (ABG) Vs Enamel Matrix Derivative (EMD) and ABG in the Treatment of Intrabony Periodontal Defects.

  • Clinical Trial
  • Mouth Disease
  • Pharmaceutical
  • Protein Therapy
  • World

Pestell, M. D., Ph. D., President of the Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S.

  • HIV AIDS
  • HIV Antiviral
  • Pathology
  • Protein Therapy
  • Therapy

Pestell, M. D., Ph. D., President of the Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S.

  • Antiviral
  • HIV AIDS
  • HIV Antiviral
  • Protein Therapy
  • Therapy

This foundation focuses on promoting, supporting, and conducting research in the fields of biotechnology, regenerative medicine, new drugs & vaccines, newgeneration medical devices, and therapies for brain disorders.

  • Medical Biotechnology
  • Pharmaceutical
  • Protein Therapy
  • Forecast
  • Merck & Co., Inc.
  • Orig3N Acquires CLIA laboratory and Remaining Assets from Interleukin Genetics

It also provides Life Capsule, a blood cell repository for regenerative medicine development.

  • Genetic Testing
  • Medical Biotechnology
  • Protein Therapy
  • United States
  • Interleukin Genetics, Inc.

A Non-inferiority Trial Periodontal Regeneration with Platelet-rich Fibrin (PRF) and Autogenous Bone Graft (ABG) Vs Enamel Matrix Derivative (EMD) and ABG in the Treatment of Intrabony Periodontal Defects.

  • Clinical Trial
  • Mouth Disease
  • Pharmaceutical
  • Protein Therapy
  • Therapy

The prominent features of this report are - ##.

  • Blood Disease
  • Protein Therapy
  • Therapy
  • World
  • Novartis AG
  • Target

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Immunotherapy
  • Pharmaceutical
  • Protein Therapy

Pursuant to the agreement, the research is funded by Regenerative Medicine Minnesota.

  • Protein Therapy
  • United States
  • Company
  • Company Financials
  • Five Prime Therapeutics, Inc.

We also see other opportunities for further growth, in such areas as Results of CMPA are expected to remain volatile in coming quarters Outlook personalized medicine including genomic medicine that incorporates advances in molecular diagnostic technologies and

  • Blood Disease
  • Clinical Trial
  • CT Scan
  • In Vitro Diagnostic Reagent
  • Protein Therapy
  • ANEMIA IN CHRONIC KIDNEY DISEASE (RENAL ANEMIA) - PIPELINE BY RELIANCE LIFE SCIENCES PVT LTD, H2 2017
  • ANEMIA IN CHRONIC KIDNEY DISEASE (RENAL ANEMIA) - PIPELINE BY JCR PHARMACEUTICALS CO LTD, H2 2017

It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases.

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • Protein Therapy
  • Therapy

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • Protein Therapy
  • Therapy
  • Vaccine

It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases.

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • Protein Therapy
  • Therapy

The EB-## program has been granted Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) and Orphan Drug Designation from the European Medicines Agency (EMA).

  • Clinical Trial
  • Dermatological Condition
  • Drug Development
  • Protein Therapy
  • Therapy

The prominent features of this report are - ##.

  • Clinical Trial
  • Pharmaceutical
  • Protein Therapy
  • Wound Care
  • World